Cargando…

Expression-based drug screening of neural progenitor cells from individuals with schizophrenia

A lack of biologically relevant screening models hinders the discovery of better treatments for schizophrenia (SZ) and other neuropsychiatric disorders. Here we compare the transcriptional responses of 8 commonly used cancer cell lines (CCLs) directly with that of human induced pluripotent stem cell...

Descripción completa

Detalles Bibliográficos
Autores principales:	Readhead, Benjamin, Hartley, Brigham J., Eastwood, Brian J., Collier, David A., Evans, David, Farias, Richard, He, Ching, Hoffman, Gabriel, Sklar, Pamela, Dudley, Joel T., Schadt, Eric E., Savić, Radoslav, Brennand, Kristen J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6200740/ https://www.ncbi.nlm.nih.gov/pubmed/30356048 http://dx.doi.org/10.1038/s41467-018-06515-4

Ejemplares similares

Author Correction: Expression-based drug screening of neural progenitor cells from individuals with schizophrenia
por: Readhead, Benjamin, et al.
Publicado: (2018)

20.4 MODELING THE CONTRIBUTION OF COMMON VARIANTS TO SCHIZOPHRENIA RISK
por: Hoffman, Gabriel, et al.
Publicado: (2018)

Transcriptional signatures of schizophrenia in hiPSC-derived NPCs and neurons are concordant with post-mortem adult brains
por: Hoffman, Gabriel E., et al.
Publicado: (2017)

Dopaminergic differentiation of schizophrenia hiPSCs
por: Hartley, Brigham J., et al.
Publicado: (2015)

What if it was easier to prevent schizophrenia than to treat it?
por: J. Brennand, Kristen
Publicado: (2017)

If there is not one cure for schizophrenia, there may be many
por: Seah, Carina, et al.
Publicado: (2020)

Better together: Non-additive interactions between schizophrenia risk genes
por: Deans, P.J. Michael, et al.
Publicado: (2023)

20. THE APPLICATION OF STEM CELL MODELS TO VALIDATE RARE AND COMMON VARIANTS CONTRIBUTING TO SCHIZOPHRENIA
por: Brennand, Kristen
Publicado: (2018)

Prospects for Modeling Abnormal Neuronal Function in Schizophrenia Using Human Induced Pluripotent Stem Cells
por: Prytkova, Iya, et al.
Publicado: (2017)

Transcriptional signatures of participant-derived neural progenitor cells and neurons implicate altered Wnt signaling in Phelan-McDermid syndrome and autism
por: Breen, Michael S., et al.
Publicado: (2020)

Synergistic effects of common schizophrenia risk variants
por: Schrode, Nadine, et al.
Publicado: (2019)

Integrative transcriptome imputation reveals tissue-specific and shared biological mechanisms mediating susceptibility to complex traits
por: Zhang, Wen, et al.
Publicado: (2019)

Increased abundance of translation machinery in stem cell–derived neural progenitor cells from four schizophrenia patients
por: Topol, A, et al.
Publicado: (2015)

Evolving toward a human-cell based and multiscale approach to drug discovery for CNS disorders
por: Schadt, Eric E., et al.
Publicado: (2014)

New considerations for hiPSC-based models of neuropsychiatric disorders
por: Hoffman, Gabriel E., et al.
Publicado: (2018)

Molecular systems evaluation of oligomerogenic APP(E693Q) and fibrillogenic APP(KM670/671NL)/PSEN1(Δexon9) mouse models identifies shared features with human Alzheimer's brain molecular pathology
por: Readhead, B, et al.
Publicado: (2016)

Evaluating Synthetic Activation and Repression of Neuropsychiatric-Related Genes in hiPSC-Derived NPCs, Neurons, and Astrocytes
por: Ho, Seok-Man, et al.
Publicado: (2017)

Gene Expression Elucidates Functional Impact of Polygenic Risk for Schizophrenia
por: Fromer, Menachem, et al.
Publicado: (2016)

PI3K inhibitors protect against glucocorticoid-induced skin atrophy
por: Agarwal, Shivani, et al.
Publicado: (2019)

Sexual dimorphism in atrophic effects of topical glucocorticoids is driven by differential regulation of atrophogene REDD1 in male and female skin
por: Baida, Gleb, et al.
Publicado: (2020)

Global landscape and genetic regulation of RNA editing in cortical samples from individuals with schizophrenia
por: Breen, Michael S., et al.
Publicado: (2019)

In utero exposure to maternal smoking is associated with DNA methylation alterations and reduced neuronal content in the developing fetal brain
por: Chatterton, Zac, et al.
Publicado: (2017)

Accurately Assessing the Risk of Schizophrenia Conferred by Rare Copy-Number Variation Affecting Genes with Brain Function
por: Raychaudhuri, Soumya, et al.
Publicado: (2010)

Evaluating Historical Candidate Genes for Schizophrenia
por: Farrell, Martilias, et al.
Publicado: (2015)

Deep learning-based brain transcriptomic signatures associated with the neuropathological and clinical severity of Alzheimer’s disease
por: Wang, Qi, et al.
Publicado: (2021)

The Importance of Non-neuronal Cell Types in hiPSC-Based Disease Modeling and Drug Screening
por: Gonzalez, David M., et al.
Publicado: (2017)

Reduced LYNX1 expression in transcriptome of human iPSC-derived neural progenitors modeling fragile X syndrome
por: Talvio, Karo, et al.
Publicado: (2022)

Human iPSC Neurons Display Activity-Dependent Neurotransmitter Secretion: Aberrant Catecholamine Levels in Schizophrenia Neurons
por: Hook, Vivian, et al.
Publicado: (2014)

An Efficient Platform for Astrocyte Differentiation from Human Induced Pluripotent Stem Cells
por: TCW, Julia, et al.
Publicado: (2017)

GJA1 (connexin43) is a key regulator of Alzheimer’s disease pathogenesis
por: Kajiwara, Yuji, et al.
Publicado: (2018)

Systematic Analysis of Environmental Chemicals That Dysregulate Critical Period Plasticity-Related Gene Expression Reveals Common Pathways That Mimic Immune Response to Pathogen
por: Smith, Milo R., et al.
Publicado: (2020)

Longitudinal data in peripheral blood confirm that PM20D1 is a quantitative trait locus (QTL) for Alzheimer’s disease and implicate its dynamic role in disease progression
por: Wang, Qi, et al.
Publicado: (2020)

Does the CAPON Gene Confer Susceptibility to Schizophrenia?
por: Eastwood, Sharon L
Publicado: (2005)

Integrative approach to sporadic Alzheimer’s disease: deficiency of TYROBP in cerebral Aβ amyloidosis mouse normalizes clinical phenotype and complement subnetwork molecular pathology without reducing Aβ burden
por: Haure-Mirande, Jean-Vianney, et al.
Publicado: (2018)

Correction: Integrative approach to sporadic Alzheimer’s disease: deficiency of TYROBP in cerebral Aβ amyloidosis mouse normalizes clinical phenotype and complement subnetwork molecular pathology without reducing Aβ burden
por: Haure-Mirande, Jean-Vianney, et al.
Publicado: (2018)

Non-additive effects of schizophrenia risk genes reflect convergent downstream function
por: Deans, PJ Michael, et al.
Publicado: (2023)

Modeling psychiatric disorders through reprogramming
por: Brennand, Kristen J., et al.
Publicado: (2012)

variancePartition: interpreting drivers of variation in complex gene expression studies
por: Hoffman, Gabriel E., et al.
Publicado: (2016)

A Network-Biology Informed Computational Drug Repositioning Strategy to Target Disease Risk Trajectories and Comorbidities of Peripheral Artery Disease
por: Shameer, Khader, et al.
Publicado: (2018)

Automated Detection of Off-Label Drug Use
por: Jung, Kenneth, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_gdd515a996v9ssb5ubdm0qj4gt